FEB 23, 2017 6:00 AM PST

Validation and Commercialization of Liquid Biopsy in a CLIA Lab

Speaker
  • President and CEO at Biocept
    Biography
      Mr. Nall has over 25 years of healthcare sales and marketing experience, most recently serving at Clarient Diagnostic Services, Inc. in positions of increasing responsibility from 2002 through August 2013, with his last position being General Manager, North American Sales and Marketing. While at Clarient, Mr. Nall was also responsible for leading the team assimilating Clarient into GE Healthcare after Clarient was acquired in 2010. From 1988 until joining Clarient, Mr. Nall served in the diagnostic and medical device industries in various commercial leadership roles for companies including Impath, American Cyanamid, Maquet Surgical, Strato Medical, Horizon Medical Products and Columbia Vital Systems. Mr. Nall received a Bachelor of Science degree in Business Administration from Central Missouri State University (now known as the University of Central Missouri).

    Abstract

    Liquid Biopsies are gaining acceptance in the Oncology community as a surrogate or complement to the gold standard of tissue biopsy.  A liquid biopsy provides biomarker information that a physician needs to understand in order to choose the best therapy for a patient. 

    Biocept is a San Diego, CA based company with cutting edge cancer diagnostics developed to capture and analyze circulating tumor cells (CTCs) as well as cell-free circulating tumor DNA (CtDNA).   The company has 18 patents issued on it’s proprietary technology that it uses to perform testing on patient samples through it’s CLIA and CAP accredited laboratory. 

    The company has validated 13 assays and currently markets these tests worldwide. 

    The talk will explain the company’s offerings in detail and also cover key points about the very large opportunity to help patients through liquid biopsy. 

    Learning Objective 1:Reasons why physicians use liquid biopsy today and where the uses are trending for the future

    Learning Objective 2:Biocept technology overview for both CTC and CTDNA capture and biomarker analysis

    Learning Objective 3:Validation results for Biocept Target Selector Assays

    Learning Objective 4: Partners for clinical validation along with publications, poster and abstract overview

     


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    FEB 23, 2017 6:00 AM PST

    Validation and Commercialization of Liquid Biopsy in a CLIA Lab


    Specialty

    Dna Sequencing

    Pcr/rt-Pcr/real-Time Pcr

    Cell Culture

    Cancer Diagnostics

    Immunology

    Cancer Research

    Molecular Biology

    Oncology

    Dna

    Molecular Diagnostics

    Biotechnology

    Laboratory Testing

    Health

    Biology

    Drug Discovery

    Geography

    North America40%

    Asia40%

    Europe20%

    Registration Source

    Website Visitors100%

    Job Title

    Medical Laboratory Technician40%

    Student20%

    Clinical Laboratory Scientist20%

    Medical Doctor/Specialist20%

    Organization

    Academic Institution40%

    Biotech Company20%

    Manufacturer - Other20%

    Hospital20%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more